Literature DB >> 24757467

Triple primary origin tumor: a case report.

Yong-Su Jung1, Se-Hoon Kim1, Sung-Kon Ha1, Sang-Dae Kim1, Dong-Jun Lim1.   

Abstract

Generally, among the extradural spinal tumors, metastatic spinal tumor is much more common than primary spinal tumors. Thus, in the case of a spinal tumor patient with cancer history (such as lung cancer, breast cancer, etc.), we used to infer that the spinal lesion is the metastasis from, primary malignancy. We introduce an experience of a case of triple primary origin tumor in a 57-year-old man. When the spinal lesion was found on the abdominal computed tomography scan, he already had a history of colon cancer and liver cancer. Initially, it was thought that the lesion would probably be a metastatic tumor from the liver or colon cancers, and the operation was performed accordingly. In the pathologic final report, however, the mass was proven to plasmacytoma - the third primary lesion. The patient underwent chemotherapy after surgery. Globally, the triple primary origin tumor has been reported very rarely. With this report, we wish to emphasize the necessity of pathologic confirmation and adequate treatment even in a patient with known malignancies.

Entities:  

Keywords:  Pathologic diagnosis; Primary spinal tumor; Spinal metastasis; Triple primary origin tumor

Year:  2013        PMID: 24757467      PMCID: PMC3941720          DOI: 10.14245/kjs.2013.10.2.91

Source DB:  PubMed          Journal:  Korean J Spine        ISSN: 1738-2262


  6 in total

Review 1.  The diagnosis and treatment of metastatic spinal tumor.

Authors:  M H Bilsky; E Lis; J Raizer; H Lee; P Boland
Journal:  Oncologist       Date:  1999

2.  Surgical treatment of metastatic spinal tumor.

Authors:  Hongguang Xu; Yipeng Wang; Guixing Qiu; Qibin Ye; Jia Zhang
Journal:  Chin Med Sci J       Date:  2002-09

3.  Multiple myeloma. Clinical practice guidelines in oncology.

Authors:  Kenneth C Anderson; Melissa Alsina; William Bensinger; J Sybil Biermann; Asher Chanan-Khan; Raymond L Comenzo; Carlos M De Castro; Benjamin Djulbegovic; Sherif Farag; Carol Ann Huff; Ruby Meredith; Jeffrey Schriber; Dennis Shrieve; Seema Singhal; Mitchell R Smith; Keith Stockerl-Goldstein; Julie M Vose; Donna Weber; Joachim Yahalom; Furhan Yunus
Journal:  J Natl Compr Canc Netw       Date:  2007-02       Impact factor: 11.908

4.  Carbon ion radiotherapy for sacral chordoma.

Authors:  R Imai; T Kamada; S Sugahara; H Tsuji; H Tsujii
Journal:  Br J Radiol       Date:  2011-03-22       Impact factor: 3.039

Review 5.  Chordoma of the sacrum and vertebral bodies.

Authors:  Daniel M Sciubba; Jennifer J Cheng; Rory J Petteys; Kristy L Weber; Deborah A Frassica; Ziya L Gokaslan
Journal:  J Am Acad Orthop Surg       Date:  2009-11       Impact factor: 3.020

6.  Chordoma: clinical characteristics, management and prognosis of a case series of 25 patients.

Authors:  Virginia Ferraresi; Carmen Nuzzo; Carmine Zoccali; Ferdinando Marandino; Antonello Vidiri; Nicola Salducca; Massimo Zeuli; Diana Giannarelli; Francesco Cognetti; Roberto Biagini
Journal:  BMC Cancer       Date:  2010-01-28       Impact factor: 4.430

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.